An experimental comparison of two different technetium source activities which can imitate thyroid scintigraphy in case of thyroid toxic nodule.
OBJECTIVE
In cases of thyroid toxic autonomous nodule, anterior projection of Tc-99m pertechnetate image shows a hot nodule that occupies most, or the entire thyroid lobe with near-total or total suppression of the contra lateral lobe. In this case is very difficult to distinguish toxic nodule from lobe agenesis. Our interest was to estimate and determinate the rate of radioactivity when the source with high activity can make total suppression of the second source with low activity in same conditions with thyroid scintigraphy procedures.


METHODS
Thyroid scintigraphy was performed with Technetium 99 meta stable pertechnetate. A parallel high resolution low energy collimator was used as an energy setting of 140 KeV photo peak for T-99m. Images are acquired at 200 Kilo Counts in the anterior projection with the collimator positioned as close as the patient's extended neck (approximately in distance of 18 cm). The scintigraphy of thyroid gland was performed 15 minutes after intravenous administration of 1.5 mCi Tc-99m pertechnetate. Technetium 99 meta stable radioactive sources with different activity were used for two scintigraphies studies, performed in same thyroid scintigraphy acquisition procedures. In the first study, were compared the standard source with high activity A=11.2 mCi with sources with variable activities B=1.33 mCi; 1.03 mCi; 0.7 mCi; 0.36 mCi; and 0.16mCi) in distance of 1.5cm from each other sources, which is approximately same with distance between two thyroid lobes. In the second study were compared the sources with low activity in proportion 70:1(source A = 1.5 mCi and source B=0.021mCi). As clinical studies we preferred two different patents with different thyroid disorders. There were one patient with thyroid toxic nodule in the right lobe, therefore the second patient was with left thyroid nodule agenesis.


RESULTS
During our examination, we accurately determined that two radioactive sources in proportion 70:1 will be displayed as only one source with complete suppression of other source with low radioactivity. Also we found that covering of toxic nodules with lead cover (plaque), can allow visualization of activity in suppressed lobe.


CONCLUSIONS
Our study concluded that total lobe suppression, in cases of patients with thyroid toxic nodule, will happened for sure, if toxic nodule had accumulated seventy times more radioactivity than normal lobe. Also we concluded that covering of the toxic nodule with lead plaque, may permit the presentation of radioactivity in suppressed nodule.
Department of Nuclear Medicine, University Clinical Centre of Kosova, Prishtina, Kosova.
Ramë
R
Miftari
Agency for protection against radiation, Goverment of Kosovo, Prishtina, Kosova.
Ferki
F
Fejza
Department of Oncology, University Clinical Centre of Kosova, Prishtina, Kosova.
Xhavit
X
Bicaj
Department of Biochemistry, University Clinical Centre of Kosova, Prishtina, Kosova.
Adem
A
Nura
Faculty of sports and physical education, University of Prishtina, Prishtina, Kosova.
Valdete
V
Topciu
Department of Nuclear Medicine, University Clinical Centre of Kosova, Prishtina, Kosova.
Ismet
I
Bajrami
lead covering; lob agenesis; radioactivity; toxic nodule